A Phase Ib Study to Assess the Safety, Tolerability and Immunologic Activity of Preoperative IRX 2 In Early Stage Breast Cancer
Phase of Trial: Phase I
Latest Information Update: 07 Mar 2017
At a glance
- Drugs Cyclophosphamide (Primary) ; Indometacin (Primary) ; IRX 2 (Primary) ; Omeprazole (Primary)
- Indications Breast cancer
- Focus Adverse reactions
- 01 Mar 2017 Planned primary completion date changed from 1 Apr 2017 to 1 Apr 2018.
- 01 Mar 2017 Status changed from not yet recruiting to recruiting.
- 09 Nov 2016 New trial record